S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.80 (+-0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   905.92 (+0.38%)
NIO   4.62 (-1.07%)
AMD   182.99 (+1.89%)
BABA   72.32 (+1.02%)
T   17.55 (+0.00%)
F   13.21 (+1.15%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   176.00 (-2.29%)
DIS   122.34 (+1.12%)
AMC   3.75 (-13.59%)
PFE   27.84 (+0.22%)
PYPL   66.94 (+0.56%)
XOM   115.38 (+0.36%)
S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.80 (+-0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   905.92 (+0.38%)
NIO   4.62 (-1.07%)
AMD   182.99 (+1.89%)
BABA   72.32 (+1.02%)
T   17.55 (+0.00%)
F   13.21 (+1.15%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   176.00 (-2.29%)
DIS   122.34 (+1.12%)
AMC   3.75 (-13.59%)
PFE   27.84 (+0.22%)
PYPL   66.94 (+0.56%)
XOM   115.38 (+0.36%)
S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.80 (+-0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   905.92 (+0.38%)
NIO   4.62 (-1.07%)
AMD   182.99 (+1.89%)
BABA   72.32 (+1.02%)
T   17.55 (+0.00%)
F   13.21 (+1.15%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   176.00 (-2.29%)
DIS   122.34 (+1.12%)
AMC   3.75 (-13.59%)
PFE   27.84 (+0.22%)
PYPL   66.94 (+0.56%)
XOM   115.38 (+0.36%)
S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.80 (+-0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   905.92 (+0.38%)
NIO   4.62 (-1.07%)
AMD   182.99 (+1.89%)
BABA   72.32 (+1.02%)
T   17.55 (+0.00%)
F   13.21 (+1.15%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   176.00 (-2.29%)
DIS   122.34 (+1.12%)
AMC   3.75 (-13.59%)
PFE   27.84 (+0.22%)
PYPL   66.94 (+0.56%)
XOM   115.38 (+0.36%)
OTCMKTS:SNWV

SANUWAVE Health (SNWV) Stock Price, News & Analysis

$0.02
0.00 (0.00%)
(As of 03/27/2024 ET)
Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.03
52-Week Range
$0.00
$0.04
Volume
585,900 shs
Average Volume
371,503 shs
Market Capitalization
$24.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SNWV stock logo

About SANUWAVE Health Stock (OTCMKTS:SNWV)

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide therapeutic treatment of musculoskeletal conditions. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

SNWV Stock Price History

SNWV Stock News Headlines

SANUWAVE Announces Record Q4 and FY2023 Revenue
This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
The AI Defense Stock Set to Soar
To protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.
SANUWAVE Announces Q2 2023 Financial Results
See More Headlines
Receive SNWV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SANUWAVE Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/16/2020
Today
3/27/2024
Next Earnings (Estimated)
4/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:SNWV
Employees
31
Year Founded
N/A

Profitability

Net Income
$-25,810,000.00
Net Margins
-126.52%
Pretax Margin
-126.50%

Debt

Sales & Book Value

Annual Sales
$20.40 million
Book Value
($0.04) per share

Miscellaneous

Outstanding Shares
1,140,560,000
Free Float
953,507,000
Market Cap
$24.59 million
Optionable
Not Optionable
Beta
1.02
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Kevin A. Richardson II (Age 56)
    Chief Strategy Officer & Director
    Comp: $470k
  • Mr. Peter Stegagno (Age 64)
    Chief Operating Officer
    Comp: $247.83k
  • Dr. Iulian Cioanta Ph.D. (Age 61)
    Chief Science & Technology Officer
    Comp: $233.68k
  • Mr. Timothy Hendricks (Age 49)
    Executive VP of Sales for U.S. Wound Business

SNWV Stock Analysis - Frequently Asked Questions

How have SNWV shares performed in 2024?

SANUWAVE Health's stock was trading at $0.0130 at the beginning of 2024. Since then, SNWV stock has increased by 65.8% and is now trading at $0.0216.
View the best growth stocks for 2024 here
.

Are investors shorting SANUWAVE Health?

SANUWAVE Health saw a drop in short interest in March. As of March 15th, there was short interest totaling 161,500 shares, a drop of 47.2% from the February 29th total of 306,100 shares. Based on an average daily trading volume, of 599,200 shares, the days-to-cover ratio is currently 0.3 days.
View SANUWAVE Health's Short Interest
.

When is SANUWAVE Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 1st 2024.
View our SNWV earnings forecast
.

How were SANUWAVE Health's earnings last quarter?

SANUWAVE Health, Inc. (OTCMKTS:SNWV) posted its quarterly earnings results on Monday, November, 16th. The company reported ($0.02) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The business earned $1.97 million during the quarter.

What guidance has SANUWAVE Health issued on next quarter's earnings?

SANUWAVE Health updated its fourth quarter 2023 earnings guidance on Tuesday, January, 30th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $6.6 million-$6.8 million.

What other stocks do shareholders of SANUWAVE Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SANUWAVE Health investors own include Co-Diagnostics (CODX), iBio (IBIO), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Digital Ally (DGLY), Kopin (KOPN), T2 Biosystems (TTOO) and VBI Vaccines (VBIV).

How do I buy shares of SANUWAVE Health?

Shares of SNWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SNWV) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners